Class IICompletedD-0141-2024
Drug recall · December 13, 2023
ceFAZolin sodium in Sterile Water for injection recall
Why: Lack of assurance of sterility.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
ceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0.1 g per mL), Syringe, Rx only, Wells Pharma, NDC 73702-131-10
- Lots / codes
Lot # 11092313110#01, Exp 01/12/24
- Quantity
- 825 syringes
- Company
- Wells Pharma of Houston LLC, Houston, TX
- Distribution
- Philadelphia, Pennsylvania.
- Initiated
- November 22, 2023 · Voluntary: Firm initiated
- Classified
- December 6, 2023
- Reported
- December 13, 2023
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cefazolin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.